{"id":"https://openalex.org/W7235200741","doi":"https://doi.org/10.21203/rs.3.rs-11731164/v1","title":"An Eight-Gene Prognostic Signature Capturing EGFR-Driven, Immune-Cold Biology in Cutaneous Melanoma","display_name":"An Eight-Gene Prognostic Signature Capturing EGFR-Driven, Immune-Cold Biology in Cutaneous Melanoma","alternate_titles":[],"publication_year":2026,"publication_date":"2026-11-17","ids":{"openalex":"https://openalex.org/W7235200741","doi":"https://doi.org/10.21203/rs.3.rs-11731164/v1"},"language":"en","primary_location":{"id":"doi:10.21203/rs.3.rs-11731164/v1","doi":"https://doi.org/10.21203/rs.3.rs-11731164/v1","is_oa":true,"landing_page_url":"https://doi.org/10.21203/rs.3.rs-11731164/v1","pdf_url":"https://www.researchsquare.com/article/rs-11731164/latest.pdf","source":{"id":"https://openalex.org/S4306525896","display_name":"Research Square","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Research Square","raw_type":"posted-content"},"parent_works":[],"lineage":["https://openalex.org/W7235200741"],"child_works_count":0,"type":"preprint","is_traditional":true,"indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://www.researchsquare.com/article/rs-11731164/latest.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5019581120","display_name":"Shafi Rehman","orcid":"https://orcid.org/0000-0002-7262-0300","observed_orcids":["https://orcid.org/0000-0002-7262-0300"]},"institutions":[{"id":"https://openalex.org/I143794436","display_name":"Khyber Medical College","ror":"https://ror.org/01vr7z878","country_code":"PK","type":"healthcare","lineage":["https://openalex.org/I143794436","https://openalex.org/I24542750"]}],"countries":["PK"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Shafi Rehman","raw_affiliation_strings":["Khyber Medical College"],"raw_orcid":"https://orcid.org/0000-0002-7262-0300","affiliations":[{"raw_affiliation_string":"Khyber Medical College","institution_ids":["https://openalex.org/I143794436"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5019581120"],"corresponding_institution_ids":["https://openalex.org/I143794436"],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":true,"cited_by_count":0,"reviewed_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.38670000433921814,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.38670000433921814,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11533","display_name":"Melanoma and MAPK Pathways","score":0.37209999561309814,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10392","display_name":"Cutaneous Melanoma Detection and Management","score":0.14659999310970306,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/cutaneous-melanoma","display_name":"cutaneous melanoma","score":0.9959999918937683},{"id":"https://openalex.org/keywords/nf1-mutation","display_name":"NF1 mutation","score":0.8389999866485596},{"id":"https://openalex.org/keywords/egfr","display_name":"EGFR","score":0.8659999966621399},{"id":"https://openalex.org/keywords/prognostic-gene-signature","display_name":"prognostic gene signature","score":0.9290000200271606},{"id":"https://openalex.org/keywords/tumor-immune-microenvironment","display_name":"tumor immune microenvironment","score":0.7749999761581421},{"id":"https://openalex.org/keywords/cd8-t-cell-exclusion","display_name":"CD8+ T cell exclusion","score":0.8939999938011169},{"id":"https://openalex.org/keywords/antigen-presentation","display_name":"antigen presentation","score":0.8709999918937683},{"id":"https://openalex.org/keywords/overall-survival","display_name":"overall survival","score":0.6399999856948853},{"id":"https://openalex.org/keywords/immune-checkpoint-inhibitors","display_name":"immune checkpoint inhibitors","score":0.33500000834465027},{"id":"https://openalex.org/keywords/immunotherapy-resistance","display_name":"immunotherapy resistance","score":0.5210000276565552},{"id":"https://openalex.org/keywords/t-cell-receptor-signaling","display_name":"T cell receptor signaling","score":0.5249999761581421},{"id":"https://openalex.org/keywords/fgf-signaling","display_name":"FGF signaling","score":0.4320000112056732},{"id":"https://openalex.org/keywords/fas-ligand","display_name":"Fas ligand","score":0.8370000123977661},{"id":"https://openalex.org/keywords/rasgrp1","display_name":"RasGRP1","score":0.8510000109672546},{"id":"https://openalex.org/keywords/flt3","display_name":"FLT3","score":0.9300000071525574}],"concepts":[{"id":"https://openalex.org/C2779733811","wikidata":"https://www.wikidata.org/wiki/Q5531562","display_name":"Gene signature","level":4,"score":0.5640000104904175},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.5231000185012817},{"id":"https://openalex.org/C2779696439","wikidata":"https://www.wikidata.org/wiki/Q7512811","display_name":"Signature (topology)","level":2,"score":0.49729999899864197},{"id":"https://openalex.org/C50382708","wikidata":"https://www.wikidata.org/wiki/Q223218","display_name":"Proportional hazards model","level":2,"score":0.4945000112056732},{"id":"https://openalex.org/C2777658100","wikidata":"https://www.wikidata.org/wiki/Q180614","display_name":"Melanoma","level":2,"score":0.48100000619888306},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.4794999957084656},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.3840999901294708},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.3747999966144562},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.3718999922275543},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.36169999837875366},{"id":"https://openalex.org/C501734568","wikidata":"https://www.wikidata.org/wiki/Q42918","display_name":"Mutation","level":3,"score":0.3587000072002411},{"id":"https://openalex.org/C167672396","wikidata":"https://www.wikidata.org/wiki/Q417800","display_name":"CD8","level":3,"score":0.3547999858856201},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.3513999879360199},{"id":"https://openalex.org/C146357865","wikidata":"https://www.wikidata.org/wiki/Q1123245","display_name":"Stage (stratigraphy)","level":2,"score":0.3395000100135803},{"id":"https://openalex.org/C37616216","wikidata":"https://www.wikidata.org/wiki/Q3218363","display_name":"Lasso (programming language)","level":2,"score":0.3239000141620636},{"id":"https://openalex.org/C10515644","wikidata":"https://www.wikidata.org/wiki/Q543310","display_name":"Survival analysis","level":2,"score":0.30809998512268066},{"id":"https://openalex.org/C2781230642","wikidata":"https://www.wikidata.org/wiki/Q492646","display_name":"Targeted therapy","level":3,"score":0.30660000443458557},{"id":"https://openalex.org/C2780674031","wikidata":"https://www.wikidata.org/wiki/Q2012719","display_name":"Cancer immunotherapy","level":4,"score":0.3061000108718872},{"id":"https://openalex.org/C70721500","wikidata":"https://www.wikidata.org/wiki/Q177005","display_name":"Computational biology","level":1,"score":0.3000999987125397},{"id":"https://openalex.org/C2777789703","wikidata":"https://www.wikidata.org/wiki/Q192102","display_name":"Skin cancer","level":3,"score":0.2994999885559082},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.296099990606308},{"id":"https://openalex.org/C179185449","wikidata":"https://www.wikidata.org/wiki/Q219699","display_name":"Suppressor","level":3,"score":0.2863999903202057},{"id":"https://openalex.org/C162317418","wikidata":"https://www.wikidata.org/wiki/Q252857","display_name":"Transcriptome","level":4,"score":0.2816999852657318},{"id":"https://openalex.org/C18431079","wikidata":"https://www.wikidata.org/wiki/Q1502169","display_name":"Gene expression profiling","level":4,"score":0.2800999879837036},{"id":"https://openalex.org/C60644358","wikidata":"https://www.wikidata.org/wiki/Q128570","display_name":"Bioinformatics","level":1,"score":0.27160000801086426},{"id":"https://openalex.org/C186836561","wikidata":"https://www.wikidata.org/wiki/Q1931516","display_name":"Microarray","level":4,"score":0.2694000005722046},{"id":"https://openalex.org/C38180746","wikidata":"https://www.wikidata.org/wiki/Q1952580","display_name":"Multivariate analysis","level":2,"score":0.26910001039505005},{"id":"https://openalex.org/C2781068499","wikidata":"https://www.wikidata.org/wiki/Q3242950","display_name":"Kidney cancer","level":3,"score":0.26420000195503235},{"id":"https://openalex.org/C2778264664","wikidata":"https://www.wikidata.org/wiki/Q422445","display_name":"Tumor suppressor gene","level":4,"score":0.25429999828338623},{"id":"https://openalex.org/C8415881","wikidata":"https://www.wikidata.org/wiki/Q6839217","display_name":"Microarray analysis techniques","level":4,"score":0.25029999017715454}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.21203/rs.3.rs-11731164/v1","doi":"https://doi.org/10.21203/rs.3.rs-11731164/v1","is_oa":true,"landing_page_url":"https://doi.org/10.21203/rs.3.rs-11731164/v1","pdf_url":"https://www.researchsquare.com/article/rs-11731164/latest.pdf","source":{"id":"https://openalex.org/S4306525896","display_name":"Research Square","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Research Square","raw_type":"posted-content"}],"best_oa_location":{"id":"doi:10.21203/rs.3.rs-11731164/v1","doi":"https://doi.org/10.21203/rs.3.rs-11731164/v1","is_oa":true,"landing_page_url":"https://doi.org/10.21203/rs.3.rs-11731164/v1","pdf_url":"https://www.researchsquare.com/article/rs-11731164/latest.pdf","source":{"id":"https://openalex.org/S4306525896","display_name":"Research Square","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Research Square","raw_type":"posted-content"},"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W7235200741.pdf","grobid_xml":"https://content.openalex.org/works/W7235200741.grobid-xml"},"referenced_works_count":21,"referenced_works":["https://openalex.org/W1950829641","https://openalex.org/W1966327575","https://openalex.org/W1996711982","https://openalex.org/W2057486011","https://openalex.org/W2070050178","https://openalex.org/W2133403796","https://openalex.org/W2164992866","https://openalex.org/W2223734406","https://openalex.org/W2332292689","https://openalex.org/W2568302777","https://openalex.org/W2594897444","https://openalex.org/W2605233023","https://openalex.org/W3031537638","https://openalex.org/W3172878008","https://openalex.org/W3212960658","https://openalex.org/W4292212641","https://openalex.org/W4365458232","https://openalex.org/W4390946922","https://openalex.org/W4411164117","https://openalex.org/W7114915772","https://openalex.org/W7213398792"],"related_works":["https://openalex.org/W3092580385","https://openalex.org/W3013111838","https://openalex.org/W4409626733","https://openalex.org/W3132424049","https://openalex.org/W4411164117","https://openalex.org/W4255967614","https://openalex.org/W3045574564","https://openalex.org/W3022427850","https://openalex.org/W2594897444","https://openalex.org/W4367624105"],"abstract_inverted_index":{"Background:":[0],"Cutaneous":[1],"melanoma":[2],"remains":[3,101],"the":[4,22,142,207,214,371,374,405,511],"deadliest":[5],"skin":[6],"cancer":[7],"despite":[8],"advances":[9],"in":[10,21,49,94,148,227,267,299,320,330,415,442,448,466,519],"targeted":[11],"therapy":[12],"and":[13,27,46,62,67,99,153,161,165,172,192,225,252,265,296,318,413,462,480,483,515],"immunotherapy.":[14],"About":[15],"14\u201327%":[16],"of":[17,223,247,287,323,332,344,452],"melanomas":[18,54],"carry":[19],"mutations":[20],"NF1":[23,41,109,169,360,383,416,439],"tumor":[24],"suppressor":[25],"gene,":[26],"these":[28],"patients":[29,189,269,476],"have":[30],"limited":[31],"options":[32],"once":[33],"immunotherapy":[34,481],"fails.":[35],"Recent":[36],"work":[37],"has":[38,87],"shown":[39],"that":[40,52,68,257,373,403,426,509],"loss":[42,384],"drives":[43],"EGFR":[44,205,315,478],"upregulation":[45],"EGFR-dependent":[47],"growth":[48],"patient-derived":[50],"models,":[51],"NF1-mutant":[53,431],"form":[55],"immune-cold":[56,92,407,456,513],"meta-niches":[57],"with":[58,96,108,136,157,168,196,243,339,359,370,438,459],"impaired":[59],"antigen":[60,275],"presentation":[61],"CD8":[63,288],"T":[64,271,289,292],"cell":[65,272,278],"exclusion,":[66],"they":[69],"harbor":[70],"a":[71,105,114,126,340,377,393,399,422,485,496,503],"proliferative,":[72],"CDC20-dependent":[73],"transcriptional":[74],"program":[75],"amenable":[76],"to":[77,307,391,430],"combination":[78],"targeting.":[79],"However,":[80],"no":[81],"bulk-tissue,":[82],"multi-cohort":[83],"gene":[84,210],"expression":[85],"signature":[86,106,127,179,220,326,375,402,420,492],"yet":[88,495],"operationalized":[89],"this":[90],"EGFR-driven,":[91,406,512],"biology":[93,156,408],"association":[95],"clinical":[97,173,498],"outcomes,":[98],"it":[100,147,434,501],"unknown":[102],"whether":[103],"such":[104],"tracks":[107],"mutation":[110,170,361,440],"status":[111,171,362,441],"or":[112],"captures":[113,376,421,454],"broader":[115,378,423],"EGFR-driven":[116,379,424],"phenotype.":[117],"Methods:":[118],"From":[119],"242":[120],"NF1/RAS":[121],"pathway":[122],"genes,":[123],"we":[124],"built":[125],"using":[128],"TCGA-SKCM":[129],"bulk":[130],"RNA-seq.":[131],"WGCNA":[132],"identified":[133],"genes":[134,216,306],"co-expressed":[135],"NF1;":[137],"LASSO":[138],"Cox":[139,229],"regression":[140],"selected":[141],"final":[143,177],"signature.":[144],"We":[145,397],"evaluated":[146],"four":[149,333],"independent":[150,222,451],"GEO":[151],"cohorts":[152,335],"characterized":[154],"its":[155],"GSVA,":[158],"immune":[159,308],"deconvolution,":[160],"single-cell":[162],"RNA-seq":[163,521],"(GSE72056),":[164],"assessed":[166],"associations":[167],"features.":[174],"Results:":[175],"The":[176,219,325,419,491],"8-gene":[178,401],"(PLA2G2D,":[180],"FASLG,":[181,312],"RASGRP1,":[182],"FLT3,":[183],"FGF1,":[184],"PLA2G5,":[185],"FGF2,":[186],"EGFR)":[187],"stratified":[188],"into":[190],"High":[191],"Low":[193],"Risk":[194],"groups":[195],"significantly":[197],"different":[198],"overall":[199],"survival":[200,447],"(log-rank":[201],"p":[202,237,349],"=":[203,212,232,241,350,353,364,367],"1.4\u00d710\u207b\u00b9\u2070).":[204],"was":[206,221,316,327,389],"only":[208,321],"risk-factor":[209],"(coefficient":[211],"+0.118);":[213],"remaining":[215],"were":[217,263],"protective.":[218],"age":[224],"stage":[226],"multivariate":[228],"analysis":[230,303,388],"(HR":[231,336],"5.32,":[233],"95%":[234],"CI":[235,347],"3.55\u20137.99,":[236],"<":[238,281],"0.001;":[239],"C-index":[240],"0.72),":[242],"time":[244],"dependent":[245],"AUCs":[246],"0.72":[248],"(1-year),":[249],"0.73":[250],"(2-year),":[251],"0.71":[253],"(3-year).":[254],"GSVA":[255],"showed":[256],"all":[258],"top":[259],"differentially":[260],"active":[261],"pathways":[262],"immune-related":[264],"downregulated":[266],"High-Risk":[268,300],"(e.g.,":[270],"receptor":[273],"signaling,":[274],"presentation,":[276],"NK":[277,294],"cytotoxicity;":[279],"FDR":[280],"10\u207b\u00b2\u2078).":[282],"Immune":[283],"deconvolution":[284],"confirmed":[285],"depletion":[286],"cells,":[290,293,295],"CD4":[291],"cytolytic":[297],"activity":[298],"tumors.":[301],"Single-cell":[302],"localized":[304],"protective":[305],"cells":[309],"(RASGRP1,":[310],"26.4%;":[311],"9.8%),":[313],"whereas":[314],"tumor-intrinsic":[317],"expressed":[319],"2.7%":[322],"cells.":[324],"directionally":[328,464],"consistent":[329,369,465],"three":[331],"external":[334,467],">":[337],"1),":[338],"pooled":[341],"meta-analysis":[342],"HR":[343],"2.25":[345],"(95%":[346],"1.03\u20134.89,":[348],"0.041;":[351],"I\u00b2":[352],"7.6%).":[354],"It":[355,445],"did":[356,435],"not":[357,428,436,494],"correlate":[358,437],"(p":[363],"0.12;":[365],"n":[366],"72),":[368],"possibility":[372],"phenotype":[380,425,457,514],"rather":[381],"than":[382],"per":[385],"se.":[386],"This":[387],"underpowered":[390],"detect":[392],"modest":[394],"association.":[395],"Conclusions:":[396],"present":[398],"bulk-tissue":[400],"operationalizes":[404,510],"recently":[409],"defined":[410],"mechanistically,":[411],"spatially,":[412],"therapeutically":[414],"mutant":[417],"melanoma.":[418],"is":[427,450,463,493,502,516],"restricted":[429],"tumors,":[432],"as":[433],"our":[443],"cohort.":[444],"stratifies":[446],"TCGA-SKCM,":[449],"stage,":[453],"an":[455],"concordant":[458],"spatial":[460],"findings,":[461],"cohorts.":[468,522],"These":[469],"findings":[470],"generate":[471],"testable":[472,518],"hypotheses":[473],"for":[474,477,488],"selecting":[475],"inhibitor":[479],"combinations":[482],"provide":[484],"bulk-computable":[486],"biomarker":[487],"prospective":[489],"testing.":[490],"validated":[497],"assay,":[499],"but":[500],"biologically":[504],"anchored,":[505],"hypothesis":[506],"generating":[507],"tool":[508],"immediately":[517],"existing":[520]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W7235200741","counts_by_year":[],"updated_date":"2026-11-21T10:27:49.728292","created_date":"2026-11-18T00:00:00"}
